https://www.epo.org/fr/boards-of-appeal/decisions/t220273eu1
T 0273/22 (Chimeric antibodies/REGENERON) du 31.08.2023
chimeric antibodies027322regenerondu
https://www.epo.org/fr/boards-of-appeal/decisions/t970669eu1
T 0669/97 (Chimeric antibodies/CELLTECH THERAPEUTICS LTD) du 03.05.2001
chimeric antibodies
https://www.epo.org/de/boards-of-appeal/decisions/t220273eu1
T 0273/22 (Chimeric antibodies/REGENERON) vom 31.08.2023
chimeric antibodies027322regeneronvom
https://www.mdpi.com/1999-4915/17/1/133
Herpesvirus Infections After Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies: A...
In this narrative review, we explore the burden and risk factors of various herpesvirus infections in patients receiving chimeric antigen receptor T-cell...
chimeric antigen receptor
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.742418/full
Frontiers | Milking the Cow: Cattle-Derived Chimeric Ultralong CDR-H3 Antibodies and Their...
In this work we have generated Epidermal Growth Factor Receptor (EGFR)-specific cattle-derived ultralong CDR-H3 antibodies by combining cattle immunization w...